Scientific and political impediments to successful islet transplantation

Diabetes

Volumn 46, Issue 8, 1997, Pages 1247-1256

  Weir, Gordon C ^a,b,c   Bonner Weir, Susan ^a,b,c  

^a JOSLIN DIABETES CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ALLOGRAFT; AUTOGRAFT; AUTOIMMUNITY; CLINICAL RESEARCH; DIABETES MELLITUS; GENE THERAPY; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; PANCREAS ISLET TRANSPLANTATION; POLITICS; PRIORITY JOURNAL; REVIEW; XENOGRAFT;

EID: 0030741524     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.8.1247     Document Type: Review

References (110)

1. Ballinger WF, Lacy PE: Transplantation of intact pancreatic islets in rats. Surgery 72: 175-186, 1972
2. Reckard CR, Barker CF: Transplantation of isolated pancreatic islets across strong and weak histocompatibility barriers. Transplant Proc 5:761-763, 1973
3. Sutherland DER, Gores PF, Hering BJ, Wahoff D, McKeehen DA, Gruessner RWG: Islet transplantation: an update. Diabetes Metab Rev 12:137-150, 1996
4. Holohan TV: Simultaneous pancreas-kidney and sequential pancreas-after-kidney tranpslantation. Health Technol Assess Rep 4:1-53, 1995
5. Stratta RJ, Weide LG, Sindhi R, Sudan D, Jerius JT, Larsen JL, Cushing K, Grune MT, Radio SJ: Solitary pancreas transplantation. Diabetes Care 20:362-368, 1997
6. Manske CL, Wang Y, Thomas W: Mortality of cadaveric kidney transplantation versus combined kidney-pancreas transplantation in diabetic patients. Lancet 346:1658-1662, 1995
7. Landgraf R: Impact of pancreas transplantation on diabetic secondary complications and quality of life. Diabetologia 39:1415-1424, 1996
8. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Bayle PJ, Falqui L, Marchetti P, Ricordi C, Gingerich RL: Results of our first nine intraportal islet allografts in type 1, insulin dependent diabetic patients. Transplantation 51:76-85, 1991
9. Socci C, Falqui L, Davalli AM, Ricordi C, Braghi S, Bertuzzi F, Maffi P, Secchi A, Gavazzi F, Freschi M: Fresh human islet transplantation to replace pancreatic endocrine function in type I diabetic patients. Acta Diabetol 28:151-157, 1991
10. Warnock G, Kneteman NM, Ryan EA, Rabinovitch A, Rajotte RV: Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 35:89-95, 1992
11. Ricordi C, Tzakis AG, Carroll PB, Zeng Y, Rilo HLR, Alejandro R, Shapiro R, Fung JJ, Demetris AJ, Mintz DH, Starzl TE: Human islet isolation and allotransplantation transplantation in 22 consecutive cases. Transplantation 53:407-414, 1992
12. Tzakis AG, Ricordi C, Alejandro R, Zeng Y, Fung JJ, Todo S, Demetris AJ, Mintz DH, Starzl TE: Pancreatic islet transplantation after upper abdominal exenteration and liver replacements. Lancet 336:402-405, 1990
13. Rajotte RV, Warnock GL, Kneteman NM: Methods of islet cryopreservation. In Pancreatic Islet Cell Transplantation. Ricordi C, Ed. Pittsburgh, PA, R.G. Landes, 1992, p. 124-131
14. Hering BJ: Insulin independence following islet transplantation in man a comparison of different recipient categories. Int Islet Transpl Registry 6:5-19, 1996
15. Pyzdrowski KL, Kendal DM, Halter JB, Nakhleh RE, Sutherland DER, Robertson RP: Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med 327:220-226, 1992
16. Ricordi C: Human islet cell transplantation: new perspectives for an old challenge. Diabetes Rev 4:356-369, 1996
17. Hauptman PJ, O'Connor KJ: Procurement and allocation of solid organs for transplantation. N Engl J Med 336:422-431, 1997
18. LaPorte RE, Matsushima M, Chang Y-F: Prevalence and incidence of insulindependent diabetes. In Diabetes in America. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 37-46 (NIH publ. no. 95-1468)
19. Kendall DM, Sutherland DER, Najarian JS, Goetz FC, Robertson RP: Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322:898-903, 1990
20. Jovanovic-Peterson L, Williams K, Brennan M, Rashbaum W, Peterson CM: Studies of human fetal pancreatic allografts in diabetic recipients without immunosuppression. J Diab Compl 3:107-112, 1989
21. Peterson CM, Jovanovic-Peterson L, Formby B, Gondos B, Monda LM, Walker L, Rashbaum W, Williams K: Human fetal pancreas transplants. J Diab Compl 3:27-34, 1989
22. Beattie GM, Otonkoski T, Lopez AD, Hayek A: Functional B-cell mass after transplantation of human fetal pancreatic cells. Diabetes 46:244-248, 1997
23. Tuch BE, Simpson AM: Experimental fetal islet transplantation. In Pancreatic Islet Cell Transplantation. Ricordi C, Ed. Pittsburgh, PA, R.G. Landes, 1992, p. 279-290
24. Ricordi C, Finke EH, Lacy PE: A method for the mass isolation of islets from the adult pig pancreas. Diabetes 35:649-653, 1986
25. Weir GC, Davalli AM, Ogawa Y, Scaglia L, Wu Y-J, Hollister J, Bonner-Weir S: Transplantation of porcine islets in nude mice: implications for islet replacement therapy in humans. Xenotransplantation 2:201-206, 1995
26. Bonner-Weir S, Davalli AM, Scaglia L, Hollister J, Weir GC: Myths about the structure and function of porcine islets. Xenotransplantation 2:207-212, 1996
27. Mandel TE, Koulmanda M, Kovarik J, Georgiou HM, Francis DMA, Dawson P, Stainsby G: Transplantation of organ cultured fetal pig pancreas in nonobese diabetic (NOD) mice and primates (Macaca fascicularis). Xenotransplantation 2:128-132, 1996
28. Korsgren O, Andersson A, Sandier S: Pretreatment of fetal porcine pancreas in culture with nicotinamide accelerates reversal of diabetes after transplantation to nude mice. Surgery 113:205-214, 1993
29. Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV: Large scale isolation, growth, and function of neonatal porcine islets. J Clin Invest 97:2119-2129, 1996
30. Jonsson J, Carlsson L, Edlund T, Edlund H: Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371:606-609, 1994
31. Bonner-Weir S: Regulation of pancreatic B-cell mass in vivo. Recent Prog Horm Res 49:91-104, 1994
32. Nielsen JH, Billestrup N, Moldrup A, Allevato G, Petersen ED, Pedersen JA, Hansen JA: Growth of the endocrine pancreas: the role of somatolactogenic hormones and receptors. Biochem Soc Trans 21:146-149, 1993
33. Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of -cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44:249-256, 1995
34. Knaack D, Fiore DM, Surana M, Leiser M, Laurance M, Fusco-DeMane D, Hegre OD, Fleischer N, Efrat S: Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes 43:1413-1417, 1994
35. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB: Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinol 130:167-178, 1992
36. Wang S, Beattie GM, Mally MI, Cirulli V, Itkin-Ansari P, Lopez AD, Hayek A, Levine F: Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplantation 6:59-67, 1997
37. Clark SA, Quaade C, Constantly H, Hansen P, Halban P, Ferber S, Newgard CB, Normington K: Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes 46:958-967, 1997
38. Hohmeier HE, BeltrandelRio H, Clark SA, Henkel-Rieger R, Normington K, Newgard CB: Regulation of insulin secretion from novel engineered insulinoma cell lines. Diabetes 46:968-977, 1997
39. Effat S, Fusco-DeMane D, Lemberg H, Al Emran O, Wang X: Conditional transformation of a pancreatic β cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 92:3576-3580, 1995
40. Diem P, Abid M, Redmon JB, Sutherland DE, Robertson RP: Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 39:534-540, 1990
41. Haffher SM: Cardiovascular risk factors and the prediabetic syndrome. Ann Med 28:363-370, 1996
42. Gupta V, Wahoff DC, Rooney DP, Poitout V, Sutherland DE, Kendall DM, Robertson RP: The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes 46:28-33, 1997
43. Kendall DM, Teuscher AU, Robertson RP: Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes 46:23-27, 1997
44. Weir GC, Bonner-Weir S, Leahy Jk Islet mass and function in diabetes and transplantation. Diabetes 39:401-405, 1990
45. Keymeulen B, Korbutt G, De Paepe M, Gorus F, Kloppel G, Pipeleers DG: Long-term metabolic control by rat islet grafts depends on the composition of the implant Diabetes 45:1814-1821, 1996
46. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC: Vulnerability of islets in the immediate post transplantation period. Diabetes 45:1161-1167, 1996
47. Weir GC, Bonner-Weir S: Experimental islet transplantation. In Yearbook of Cell and Tissue Transplantation 1996/1997. Lanza RP, Chick WL, Eds. Dordrecht, The Netherlands, Kluwer Academic, 1996, p. 145-152
48. Bonner-Weir S, Orci L: New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31:883-939, 1982
49. Weir GC, Bonner-Weir S: Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. J Clin Invest 85:983-987, 1990
50. Stagner JI, Mokshagundam S, Samols E: Hormone secretion from transplanted islets is dependent upon changes in islet revascularization and islet architecture. Transplant Proc 27:3251-3254, 1995
51. Holz GG, Kuhtreiber WM, Habener JF: Pancreatic beta-cells are rendered glucose-competent by insulinotropic hormone glucagon-like peptide. Nature 361:362-365, 1993
52. Lacy PE: Treating diabetes with transplanted cells. Scientific American 273:54-58, 1995
53. Sutherland DER, Goetz FC, Sibley RK: Recurrence of disease in pancreas transplants. Diabetes 38:85-87, 1989
54. Haskins K, Wegmann D: Diabetogenic T-cell clones. Diabetes 45:1299-1305, 1996
55. Lipes MA, Cooper EM, Skelly R, Rhodes CJ, Boschetti E, Weir GC, Davalli AM: Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc Natl Acad Sci USA 93:8596-8600, 1996
56. Bach FH, Auchincloss H Jr, Robson SC: Xenotransplantation. In Transplantation Immunology. Bach FH, Auchincloss H Jr, Eds. New York, WileyLiss, 1995, p. 305-338
57. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC: Delayed xenograft rejection. Immunol Today 17:379-384, 1996
58. Dorling A, Riesbeck K, Warrens A, Lechler R: Clinical xenotransplantation of solid organs. Lancet 349:867-871, 1997
59. McKenzie IFC, Koulmanda M, Sandrin MS, Mandel TE: Expression of gal(l,3)gal by porcine islet cells and its relevance to xenotransplantation. Xenotransplantation 2:139-142, 1996
60. Menger MD, Vajkoczy P, Beger C, Messmer K: Orientation of microvascular blood flow in pancreatic islet isografts. J Clin Invest 93:2280-2285, 1994
61. Korbutt GS, Aspeslet LJ, Rajotte RV, Warnock GL, Ao Z, Ezekowitz J, Malcolm AJ, Koshal A, Yatscoff RW: Natural human antibody-mediated destruction of porcine neonatal islet cell grafts. Xenotransplantation 3:207-216, 1996
62. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP: Risk of neoplasia in renal transplant patients. Lancet 346:403-406, 1995
63. Gremlich S, Roduit R, Thorens B: Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic B cells. J Biol Chem 272:3216-3222, 1997
64. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257:789-792, 1992
65. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA, Naji AA: Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 249:1293-1295, 1990
66. Selawry HP: Islet transplantation to immunoprivileged sites, In Pancreatic Islet Transplantation. Lanza RP, Chick WL, Eds. Pittsburgh, PA, R.G. Landes, 1994, p. 75-86
67. Colton CK, Avgoustiniatos ES: Bioengineering in development of the hybrid artificial pancreas. J Biomech Eng 113:152-170, 1991
68. Colton CK: Engineering challenges in cell encapsulation technology. Trends Biotechnology 14:158-162, 1996
69. Colton CK: Implantable biohybrid artificial organs. Cell Transplantation 4:415-436, 1995
70. Sun Y, Ma X, Zhou D, Vacek I, Sun AM: Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 98:1417-1422, 1996
71. De Vos P, De Haan BJ, Wolters GHJ, Strubbe JH, Van Schilfgaarde RV: Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 40:262-270, 1997
72. Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Zheng TZ, Murphy M, Moloney MD, Schmehl M, Harris M: Insulin independence in a type 1 diabetic patients after encapsulated islet transplantation. Lancet 343:950-951, 1994
73. Lanza RP, Chick WL Transplantation of encapsulated cells and tissues. Surgery 121:1-9, 1997
74. Calafiore R: Perspectives in pancreatic and islet cell transplantation for the therapy of IDDM. Diabetes Care 20:889-895, 1997
75. Brissova M, Petro M, Lacik I, Powers AC, Wang T: Evaluation of microcapsule permeability via inverse size exclusion chromatography. Anal Biochem 242:104-111, 1996
76. Sawhney AS, Pathak CP, Hubbell JA: Interfacial photopolymerization of poly (ethylene glycol)-based hydrogels upon alginate-poly (1-lysine) microcapsules for enhanced biocompatibility. Biomaterials 14:1008-1016, 1993
77. Mukhopadhyay D, Tslokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375:577-581, 1995
78. Brauker J, Martinson LA, Young SK, Johnson RC: Local inflammatory response around diffusion chambers containing xenografts. Transplantation 61:1671-1677, 1996
79. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE: Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254:1782-1784, 1991
80. + T cells and B cells. Transplantation 61:1678-1684, 1996
81. Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE: Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 43:1167-1170, 1994
82. Suzuki K, Bonner-Weir S, Hollister J, Weir GC: A method for estimating number and mass of islets transplanted within a membrane device. Cell Transplantation 5:613-625, 1996
83. Lanza RP, Butler DH, Borland KM, Staruk JE, Faustman DL, Solomon BA, Muller TE, Rupp RG, Maki T, Monaco AP, Chick WL: Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci USA 88:11100-11104, 1991
84. Maki T, Otsu I, O'Neil JJ, Dunleavy K, Mullon CJ, Solomon BA, Monaco AP: Treatment of diabetes by xenogeneic islets without immunosuppression: use of a vascularized bioartificial pancreas. Diabetes 45:342-347, 1996
85. Mulligan RC: The basic science of gene therapy. Science 260:926-931, 1993
86. Saldeen J, Curiel DT, Eizirik DL, Andersson A, Strandell E, Buschard K, Welsh N: Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes 45:1197-1203, 1996
87. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB: Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43:161-189, 1994
88. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing ceus by a lentiviral vector. Science 272:263-267, 1996
89. Efrat S, Fejer G, Brownlee M, Horwitz MS: Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc Natl Acad Sci USA 92:6947-6951, 1995
90. Deng S, Ketchum RJ, Kucher T, Weber M, Shaked A, Naji A, Brayman KL: Adenoviral transfrection of canine islet xenografts with immunosuppressive cytokine genes abrogates primary nonfunction and prolongs graft survival. Transplant Proc 29:770, 1997
91. Gainer AL, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF: Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival. Transplantation 63:1017-1044, 1997
92. Welsh N, Bendtzen K, Welsh M: Expression of an insulin/interleukin-1 antag onist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production. J Clin Invest 95:1717-1722, 1995
93. Hunger RE, Muller S, Laissue JA, Hess MW, Carnaud C, Garcia I, Mueller C: Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. J clin Invest 98:954-961, 1996
94. Lau HT, Yu M, Fontana A, Stoeckert CJ Jr Prevention of islet allograft rejection with engineered myoblasts expressing fas-L in mice. Science 273:109-111, 1996
95. Korbutt GS, Elliott JF, Rajotte RV: Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46:317-322, 1997
96. Chao DT, Unette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ: BclXL and Bcl-2 repress a common pathway of cell death. J Exp Med 182:821-828, 1995
97. Sarma V, Lin Z, Clark L, Rust BM, Tewari M, Noelle RJ, Dixit VM: Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J Biol Chem 270:12343-12346, 1995
98. Welsh N, Margulis B, Borg LA, Wiklund HJ, Saldeen J, Flodstrom M, Mello MA, Andersson A, Pipeleers DG, Hellerstrom C: Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes meliitus. Molecular Med 1:806-520, 1995
99. White DJ, Yanoutsos N: Production of pigs transgenic for human DAF to over-come complement-mediated hyperacute xenograft rejection in man. Res Immunol 147:88-94, 1996
100. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS: Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63:149-155, 1997
101. Borlaug R: Wrap it up I'll take it the race to perfect islet cell transplants. Diabetes Interview 57:1-19, 1997
102. Keller RJ, Eisenbarth GS, Jackson RA Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341:927-928, 1993
103. Gale EAM, Bingley PJ: Can we prevent IDDM? Diabetes Care 17:339-344, 1994
104. Skolnick AA: First type I diabetes prevention trials. JAMA 14:1101-1102, 1997
105. Weir GC, Bonner-Weir S: Insulin secretion in non-insulin-dependent diabetes mellitus, In Diabetes Mellitus. LeRoith D, Taylor SI, Olefsky JM, Eds. Philadelphia, PA, Lippincott-Raven, 1996, p. 503-508
106. Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis KS: Withholding research results in academic life science. JAMA 277:1224-1228, 1997
107. Stoye JP: Proviruses pose potential problems. Nature 386:126-127, 1997
108. Will RG, Knight RSG, Zeidler M, Stewart G, Ironside JW, Cousens SN, Smith PG: Reporting of suspect new variant Creutzfeldt-Jakob disease. Lancet 349:847, 1997
109. Patience C, Takeuchi Y, Weiss RA: Infection of human cells by an endogenous retrovirus of pigs. Nature Med 3:282-286, 1997
110. Williams N: Xenotransplantation: pig-human transplants barred for now. Science 275:473, 1997